Background Centralised drug purchasing in a Regional Health Service enhances efficiency
in drugs' procurement and ensures that all hospitals in charge of the health service get the …

Background and Importance Individualised treatments are the most important oncology
pharmacotherapeutic innovation nowadays. The high cost of such treatments may hinder …

Background Benlysta is a human monoclonal antibody that is indicated as add-on treatment
in adult patients with active, autoantibody-positive (antinuclear antibodies ANA≥ 1/80) …

Background The addition of a pharmacist during the validation, preparation and
administration of cytostatics ensures the detection and resolution of drug-related problems …

Background Many medicines prescribed for children have not been formally studied.
Therefore, most of them are not labelled to be used in paediatric patients (PP). The …

Background Although hepatitis B (HB) drugs have strong antiviral activity, they cannot
eradicate the virus, so they must be administered for long periods of time, making long-term …

Background Pazopanib is a protein kinase inhibitor. It is indicated in adults for the treatment
of advanced Renal Cell Carcinoma (RCC) and the treatment of patients with particular …

Background Occupational exposure to hazardous drugs (HDs) is a mounting public health
concern. Nevertheless, currently there are not harmonised standards for the prevention of …

Background The register and assessment of queries received in a centralised health service
(CHS) from hospital pharmacists and other professionals allow knowledge of high demand …

Background Numerous studies have shown that the presence of a pharmacist on hospital
rounds as a full member of the patient care team prevents drug errors. Purpose To analyse …